Catherine T. Doherty

2017

In 2017, Catherine T. Doherty earned a total compensation of $2.5M as Senior Vice President, Group Executive Clinical Franchises at Quest Diagnostics, a 1% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$419,175
Option Awards$599,924
Salary$575,000
Stock Awards$900,090
Other$37,827
Total$2,532,016

Doherty received $900.1K in stock awards, accounting for 36% of the total pay in 2017.

Doherty also received $419.2K in non-equity incentive plan, $599.9K in option awards, $575K in salary and $37.8K in other compensation.

Rankings

In 2017, Catherine T. Doherty's compensation ranked 4,373rd out of 14,666 executives tracked by ExecPay. In other words, Doherty earned more than 70.2% of executives.

ClassificationRankingPercentile
All
4,373
out of 14,666
70th
Division
Services
830
out of 2,424
66th
Major group
Health Services
72
out of 224
68th
Industry group
Medical And Dental Laboratories
17
out of 64
73rd
Industry
Medical Laboratories
17
out of 64
73rd
Source: SEC filing on April 4, 2018.

Doherty's colleagues

We found four more compensation records of executives who worked with Catherine T. Doherty at Quest Diagnostics in 2017.

2017

Stephen Rusckowski

Quest Diagnostics

Chief Executive Officer

2017

Mark Guinan

Quest Diagnostics

Chief Financial Officer

2017

James Davis

Quest Diagnostics

Executive Vice President, General Diagnostics

2017

Carrie Manner

Quest Diagnostics

Senior Vice President Advanced Diagnostics

News

You may also like